Clinical effects of hypertension on the mortality of patients with acute myocardial infarction

Journal of Korean Medical Science

Volumn 24, Issue 5, 2009, Pages 800-806

  Kang, Dong Goo ^a   Jeong, Myung Ho ^b   Ahn, Yongkeun ^b   Chae, Shung Chull ^c   Hur, Seung Ho ^d   Hong, Taek Jong ^e   Kim, Young Jo ^f   Seong, In Whan ^g   Chae, Jei Keon ^h   Rhew, Jay Young ⁱ   Chae, In Ho ^j   Cho, Myeong Chan ^k   Bae, Jang Ho ^l   Rha, Seung Woon ^m   Kim, Chong Jin ⁿ   Jang, Yang Soo ^o   Yoon, Junghan ^p   Seung, Ki Bae ^q   Park, Seung Jung ^r  

^a Gwangju Christian Hospital   (South Korea)

^b Chonnam National University   (South Korea)

^c Kyungpook National University   (South Korea)

^d Dongsan Medical Center   (South Korea)

^e Pusan National University Hospital   (South Korea)

^f Young Nam University Hospital   (South Korea)

^g Chungnam National University College of Medicine   (South Korea)

^h Chonbuk National University Medical School   (South Korea)

ⁱ Jeonju Presbyterian Medical Center   (South Korea)

^j Seoul National University Bundang Hospital   (South Korea)

^k Chungbuk National University   (South Korea)

^l Konyang University   (South Korea)

^m Korea University College of Medicine   (South Korea)

ⁿ Kyung Hee University College of Medicine   (South Korea)

^o Yonsei University College of Medicine   (South Korea)

^p Wonju Severance Christian Hospital   (South Korea)

^q The Catholic University of Korea   (South Korea)

^r University of Ulsan   (South Korea)

more..

Author keywords

Hypertension; Mortality; Myocardial infarction

Indexed keywords

ACUTE DISEASE; AGE; AGED; ARTICLE; CEREBROVASCULAR DISEASE; DIABETES MELLITUS; FEMALE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; MIDDLE AGED; MORTALITY; PERIPHERAL VASCULAR DISEASE; PREDICTION AND FORECASTING; REGISTER; SEX DIFFERENCE;

ACUTE DISEASE; AGE FACTORS; AGED; CEREBROVASCULAR DISORDERS; DIABETES MELLITUS; FEMALE; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERIPHERAL VASCULAR DISEASES; PREDICTIVE VALUE OF TESTS; REGISTRIES; SEX FACTORS;

EID: 75349112192     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2009.24.5.800     Document Type: Article

References (29)

1. Lewis EF, Moye LA, Rouleau JL, Sacks FM, Arnold JM, Warnica JW, Flaker GC, Braunwald E, Pfeffer MA; CARE Study. Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study. J Am Coll Cardiol 2003; 42: 1446-53.
2. Richards AM, Nicholls MG, Troughton RW, Lainchbury JG, Frampton C, Espiner EA, Crozier IG, Yandle TG, Turner J. Antecedent hypertension and heart failure after myocardial infarction. J Am Coll Cardiol 2002; 39: 1182-8.
3. Witt BJ, Ballman KV, Brown RD Jr, Meverden RA, Jacobsen SJ, Roger VL. The incidence of stroke after myocardial infarction: a meta-analysis. Am J Med 2006; 119: 354. e1-9.
4. Miura K, Daviglus ML, Dyer AR, Liu K, Garside DB, Stamler J, Greenland P. Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: The Chicago Heart Association Detection Project in Industry. Arch Intern Med 2001; 161: 1501-8.
5. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-13.
6. Willich SN, Müller-Nordhorn J, Kulig M, Binting S, Gohlke H, Hahmann H, Bestehorn K, Krobot K, Völler H; PIN Study Group. Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease; a prospective cohort study. Eur Heart J 2001; 22: 307-13.
7. Piegas LS, Avezum A, Pereira JC, Neto JM, Hoepfner C, Farran JA, Ramos RF, Timerman A, Esteves JP; AFIRMAR Study Investigators. Risk factors for myocardial infarction in Brazil. Am Heart J 2003; 146: 331-8.
8. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, Mc-Queen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-52.
9. Richards AM, Nicholls MG, Troughton RW, Lainchbury JG, Elliott J, Frampton C, Espiner EA, Crozier IG, Yandle TG, Turner J. Antecedent hypertension and heart failure after myocardial infarction. J Am Coll Cardiol 2002; 39: 1182-8.
10. Thune JJ, Signorovitch J, Kober L, Velazquez EJ, McMurray JJ, Califf RM, Maggioni AP, Rouleau JL, Howlett J, Zelenkofske S, Pfeffer MA, Solomon SD. Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction. Hypertension 2008; 51: 48-54.
11. Rakugi H, Yu H, Kamitani A, Nakamura Y, Ohishi M, Kamide K, Nakata Y, Takami S, Higaki J, Ogihara T. Links between hypertension and myocardial infarction. Am Heart J 1996; 132: 213-21.
12. Korea Acute Myocardial Infarction Registry (KAMIR) Investigators, Lee KH, Jeong MH, Ahn YK, Kim JH, Chae SC, Kim YJ, Hur SH, Seong IW, Hong TJ, Choi D, Cho MC, Kim CJ, Seung KB, Chung WS, Jang YS, Cho JG, Park SJ; Other Korea Acute Myocardial Infarction Registry Investigators. Gender differences of success rate of percutaneous coronary intervention and short term cardiac events in Korea Acute Myocardial Infarction Registry. Int J Cardiol 2008; 130: 227-34.
13. Lee SR, Jeong MH, Ahn YK, Chae SC, Hur SH, Kim YJ, Seong IW, Chae JK, Hong TJ, Rhew JY, Cho MC, Bae JH, Rha SW, Kim CJ, Jang YS, Park SJ; Korea Acute Myocardial Infarction Registry Investigators. Clinical safety of drug-eluting stents in the Korea acute myocardial infarction registry. Circ J 2008; 72: 392-8.
14. Pastor-Barriuso R, Banegas JR, Damian J, Appel LJ. Systolic blood pressure, diastolic blood pressure, and pulse pressure: an evaluation of their joint effect on mortality. Ann Intern Med 2003; 139: 731-9.
15. Sipahi I, Tuzcu EM, Schoenhagen P, Wolski KE, Nicholls SJ, Balog C, Crowe TD, Nissen SE. Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis. J Am Coll Cardiol 2006; 48: 833-8.
16. Kenchaiah S, Davis BR, Braunwald E, Rouleau JL, Dagenais GR, Sussex B, Steingart RM, Brown EJ Jr, Lamas GA, Gordon D, Bernstein V, Pfeffer MA; Survival and Ventricular Enlargement Trial. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial. Am Heart J 2004; 148: 356-64.
17. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, Evans A, Ferrario M, Tuomilehto J. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000; 355: 675-87.
18. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, Giles WH, Capewell S. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007; 356: 2388-98.
19. Khor GL. Cardiovascular epidemiology in the Asia-Pacific region. Asia Pac J Clin Nutr 2001; 10: 76-80.
20. Ko M, Kim MT, Nam JJ. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey. Int J Cardiol 2006; 110: 184-90.
21. Majahalme SK, Smith DE, Cooper JV, Kline-Rogers E, Mehta RH, Eagle KA, Bisognano JD. Comparison of patients with acute coronary syndrome with and without systemic hypertension. Am J Cardiol 2003; 92: 258-63.
22. Mehta RH, Roe MT, Chen AY, Lytle BL, Pollack CV Jr, Brindis RG, Smith SC Jr, Harrington RA, Fintel D, Fraulo ES, Califf RM, Gibler WB, Ohman EM, Peterson ED. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative. Arch Intern Med 2006; 166: 2027-34.
23. Keeley, EC, Boura, JA, Grines, CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20.
24. Song YB, Hahn JY, Gwon HC, Kim JH, Lee SH, Jeong MH; KAMIR investigators. The impact of initial treatment delay using primary angioplasty on mortality among patients with acute myocardial infarction: from the Korea Acute Myocardial Infarction Registry. J Korean Med Sci 2008; 23: 357-64.
25. Mauri F, Maggioni AP, Franzosi MG, de Vita C, Santoro E, Santoro, Giannuzzi P, Tognoni G. A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent. A Gruppo Italiano per lo Studio della So-pravvivenza nell' Infarto Miocardico (GISSI-2)-Derived Analysis. J Coll Cardiol 1994; 24: 600-7.
26. Devereux RB, Roman MJ. Inter-relationships between hypertension, ventricular hypertrophy and coronary heart disease. J Hypertens 1993; 11 (Suppl): S3-9.
27. Herlitz J, Bång A, Karlson BW. Five-year prognosis after acute myocardial infarction in relation to a history of hypertension. Am J Hypertens 1996; 9: 70-6.
28. Yagi M, Nakao K, Honda T, Tsurumi Y, Kasanuki H. Clinical characteristics and early outcomes of very elderly patients in the reperfusion era. Int J Cardiol 2004; 94: 41-6.
29. White HD, Aylward PE, Huang Z, Dalby AJ, Weaver WD, Barvik, Marin-Neto JA, Murin J, Nordlander RO, van Gilst WH, Zannad F, McMurray JJ, Califf RM, Pfeffer MA; VALIANT Investigators. and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Circulation 2005; 112: 3391-9.